Kei Yoshino Selected Research

Kei Yoshino Research Topics

Disease

11	Neoplasms (Cancer) 11/2023 - 04/2011
9	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 01/2011
5	Lymphatic Metastasis 11/2016 - 06/2013
4	Neoplasm Metastasis (Metastasis) 07/2018 - 06/2013
4	Esophageal Squamous Cell Carcinoma 01/2017 - 09/2013
3	Diabetes Mellitus 12/2023 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2013 - 01/2011
2	Pheochromocytoma 11/2023 - 03/2023
2	Body Weight (Weight, Body) 11/2021 - 01/2011
2	Insulin Resistance 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 06/2014 - 11/2013
2	Inflammation (Inflammations) 01/2014 - 08/2006
1	Birth Weight (Birth Weights) 12/2023
1	Ganglioneuroma 11/2023
1	Paraganglioma (Paragangliomas) 11/2023
1	Hypertensive Crisis 03/2023
1	COVID-19 03/2023
1	Intussusception 03/2022
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Fatty Liver 11/2021
1	Hyperglycemia 11/2021
1	Cholecystolithiasis 07/2018
1	Neuroendocrine Carcinoma 11/2017
1	Cholangiocarcinoma 11/2016
1	Intestinal Perforation 11/2016
1	Peritonitis 11/2016
1	Rectal Neoplasms (Rectal Cancer) 11/2016
1	Periodontitis 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Anastomotic Leak 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015
1	Breast Neoplasms (Breast Cancer) 06/2014
1	Pharyngeal Neoplasms 01/2012
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2011
1	Melanoma (Melanoma, Malignant) 04/2011

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 04/2011
3	C-Reactive ProteinIBA 06/2014 - 11/2013
2	Insulin (Novolin)FDA Link 12/2023 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 12/2023 - 01/2022
2	CatecholaminesIBA 11/2023 - 03/2023
2	TE 5IBA 07/2015 - 01/2011
2	SmokeIBA 01/2011 - 08/2006
1	Glycated Serum AlbuminIBA 12/2023
1	Blood Glucose (Blood Sugar)IBA 12/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2023
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2023
1	Phenylethanolamine N-MethyltransferaseIBA 11/2023
1	GlucocorticoidsIBA 03/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023
1	landiololIBA 03/2023
1	Dinoprostone (PGE2)FDA Link 11/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021
1	Sodium-Glucose Transport ProteinsIBA 11/2021
1	CanagliflozinIBA 11/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	ProinsulinIBA 01/2021
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2020
1	Leukotriene B4IBA 01/2020
1	SynaptophysinIBA 07/2018
1	Chromogranin AIBA 07/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2017
1	LigandsIBA 01/2017
1	Bevacizumab (Avastin)FDA Link 11/2016
1	Gemcitabine FDA Link 11/2016
1	CreatinineIBA 01/2016
1	ferumoxides (Feridex)FDA Link 08/2015
1	Contrast MediaIBA 08/2015
1	Ferrosoferric Oxide (Magnetite)FDA Link 08/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Hyaluronic Acid (Hyaluronan)IBA 11/2013
1	AntibodiesIBA 11/2013
1	Interleukin-10 (Interleukin 10)IBA 07/2011
1	InterferonsIBA 07/2011
1	Interleukin-2 (IL2)IBA 07/2011
1	CytokinesIBA 07/2011
1	Interleukin-4 (Interleukin 4)IBA 07/2011
1	Dacarbazine (DIC)FDA LinkGeneric 04/2011
1	NimustineIBA 04/2011

Therapy/Procedure

8	Esophagectomy 01/2017 - 04/2011
5	Lymph Node Excision (Lymph Node Dissection) 07/2018 - 06/2013
5	Radiotherapy 01/2016 - 01/2011
4	Drug Therapy (Chemotherapy) 11/2017 - 04/2011
3	Therapeutics 12/2023 - 04/2011
3	Adjuvant Chemotherapy 01/2017 - 04/2011
2	Neoadjuvant Therapy 01/2017 - 01/2016
2	Chemoradiotherapy 01/2017 - 01/2015
1	Critical Care (Surgical Intensive Care) 03/2023
1	Colectomy 03/2022
1	Exercise Therapy (Therapy, Exercise) 01/2021
1	Laparoscopic Cholecystectomy 07/2018
1	Colostomy 11/2016
1	Cecostomy 11/2016
1	Dental Care 01/2016
1	Renal Dialysis (Hemodialysis) 01/2016
1	Thoracotomy 01/2015
1	Cardiopulmonary Resuscitation (CPR) 11/2013